Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/08/2000EP1049706A1 New pentasaccharides, their methods of production and pharmaceutical compositions containing same
11/08/2000EP1049703A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
11/08/2000EP1049702A1 Process for purifying a solution of an ampicillin pro-drug ester
11/08/2000EP1049701A1 Tricyclic indolene substituted oxazolidinones
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049699A1 Azolo triazines and pyrimidines
11/08/2000EP1049698A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049697A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049696A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049695A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049692A1 Novel bicyclene-substituted oxazolidinones
11/08/2000EP1049691A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
11/08/2000EP1049689A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
11/08/2000EP1049686A1 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
11/08/2000EP1049684A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1049682A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation
11/08/2000EP1049679A2 Sulphonamide derivatives for treatment of cns disorders
11/08/2000EP1049677A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049672A1 Azetidinecarboxamide derivatives for treating cns disorders
11/08/2000EP1049671A1 Azetidinecarboxamide derivatives for the treatment of cns disorders
11/08/2000EP1049670A1 Azetidinecarboxamide derivatives for treating cns disorders
11/08/2000EP1049667A1 Novel naphthyl substituted and heterocyclic substituted sulfonamides
11/08/2000EP1049666A1 Novel naphthyl-substituted and anilide-substituted sulfonamides
11/08/2000EP1049665A1 Vla-4 antagonists
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000EP1049660A1 Compositions and methods for inhibiting arginase activity
11/08/2000EP1049634A1 Methods and compositions for treating dermatoses
11/08/2000EP1049478A1 Composition containing propargylamine for enhancing cancer therapy
11/08/2000EP1049477A1 Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
11/08/2000EP1049476A1 Pharmaceutical compositions for mucolysis and treatment of inflammation
11/08/2000EP1049475A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
11/08/2000EP1049474A1 Cannabimimetic lipid amides as useful medications
11/08/2000EP1049473A1 Pyrimidin 3-oxide compounds suitable for the treatment of pathologies of the skeletal muscle, in particular for the treatment of the hypokalemic paralysis
11/08/2000EP1049472A1 Antagonists of gonadotropin releasing hormone
11/08/2000EP1049471A1 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids
11/08/2000EP1049470A1 Extended release tiagabine formulations with reduced side-effects
11/08/2000EP1049469A1 Biodegradable polymer matrices for sustained delivery of anesthetics
11/08/2000EP1049468A1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049466A2 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
11/08/2000EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
11/08/2000EP1049464A2 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer
11/08/2000EP1049463A1 Use of fc101 as an angiogenesis inhibitor for the treatment of cancer and other angiogenic diseases
11/08/2000EP1049462A1 Choline esters of fatty acids and their use in the treatment of stroke
11/08/2000EP1049461A2 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
11/08/2000EP1049460A1 Method of the prophylactic treatment of mastitis
11/08/2000EP1049459A1 Oral liquid compositions
11/08/2000EP1049457A1 Bioactive glass treatment of inflammation in skin conditions
11/08/2000EP1049451A1 Compositions and method for protecting skin from uv induced immunosuppression and skin damage
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP1049424A1 A drug dosage form based on the teorell-meyer gradient
11/08/2000EP1049386A2 Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby
11/08/2000EP1049375A1 Method and compositions for promotion of wound healing
11/08/2000EP1049374A1 Tuberculocidal disinfectant
11/08/2000EP1030567A4 System, method and composition for dialysis and shock treatment
11/08/2000EP0862550B1 Carboxylic acid derivatives, their preparation and their use
11/08/2000EP0861231B1 L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthaseinhibitors
11/08/2000EP0789564A4 Polynucleotide compositions
11/08/2000EP0787000B1 Quinazolinone pharmaceuticals and use thereof
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/08/2000EP0738275B1 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
11/08/2000EP0656002B1 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/08/2000EP0650495B1 Improved antiandrogens
11/08/2000EP0637307B1 Imidazole, triazole and tetrazole derivatives
11/08/2000EP0588917B1 Isoxazole and isothiazole compounds that enhance cognitive function
11/08/2000CN1272846A 8-substituted-9H-1,3-dioxolo/4,5-h/2,3/benzodiazepine derivatives, as Ampa/kainate receptor inhibitors
11/08/2000CN1272845A Process for preparation of oxymorphone, oxycodone and derivatives
11/08/2000CN1272844A Benzo (5,6) cyclohepta (1,2-B) pyridine derivatives as farnesyl protein transferase inhibitors
11/08/2000CN1272842A 2-acylaminopropanamines as tachykinin receptor antagonists
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1272796A Polymeric derivatives of camptothecins
11/08/2000CN1272792A Herbal extract composition and method with immune-boosting capability
11/08/2000CN1272790A Method for promoting weight and fat loss with composition comprising hydroxycitrate, carnitine and pyruvate promotor
11/08/2000CN1272788A Method for treating psychosis associated with glucocorticoid related dysfunction
11/08/2000CN1272787A Sustained-release theophylline tablet
11/08/2000CN1272786A Endothelin antagonist and beta receptor blocking agent as combined preparation
11/08/2000CN1272784A Medicinal compositions for application to mucosa
11/08/2000CN1272783A Dermatological compositions
11/08/2000CN1272500A Safflower total uranidin, its preparation and application
11/08/2000CN1272499A Method for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide
11/08/2000CN1272494A Process for preparing anti-osteoporosis drug
11/08/2000CN1272493A Novel amino-triazole compound, its preparation method and drug composition containing them
11/08/2000CN1272375A Acne-eliminating capsule and liniment for curing acnes
11/08/2000CN1272374A Spot-eliminating and beautifying cream
11/08/2000CN1272372A Drink for dispelling effects of liquor and its preparation method
11/08/2000CN1272370A Eye ointment for curing myopia and its production process
11/08/2000CN1272365A Physiological active material
11/08/2000CN1272364A Gelding liquor for female livestocks
11/08/2000CN1272363A Preparation method of medicine for resisting ischemic cerebrum and brain trauma using taurine
11/08/2000CN1272362A Selective antibiotic composition
11/08/2000CN1058294C Method for preparation of compound named 'Leustroducsins'
11/08/2000CN1058266C 14-substituted marcfortines and derivatives useful as antiparasitic agents and its application
11/08/2000CN1058265C Quinazoline derivatives and its preparing method and compositions containing the same
1 ... 6214 6215 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 ... 7860